Research Paper Volume 14, Issue 6 pp 2758—2774
GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
Figure 2. Relationships between mRNA expression of GSDM family and clinicopathological features of ccRCC. (A) The relationship between mRNA expression and pathological stage of ccRCC patients with different members of the GSDM family (GEPIA2). (B) The relationship between mRNA expression and tumor grade of ccRCC patients with different members of the GSDM family (TISIDB). * p < 0.05, ** p < 0.01, *** p < 0.001.